Health & Wellness

07/27/2026 · Marion

FDA Approves Oral PCSK9 Inhibitor for Cholesterol Reduction

The U.S. Food and Drug Administration has approved Lipfendra (enlicitide), an oral medication designed to lower LDL cholesterol. This approval marks the first time an oral PCSK9 inhibitor has received authorization for use in adults with high cholesterol.

07/27/2026

Read Story

Health

Healthcare-Associated Infections Declined in 2023, CDC Reports

New data from the Centers for Disease Control and Prevention indicates a decline in healthcare-associated infections during 2023. These findings highlight changes within patient safety initiatives.

07/26/2026 · Virginia

Health

FDA Proposes Rule to Enhance Oversight of Foreign Tobacco Products

The U.S. Food and Drug Administration has proposed a new rule to strengthen its ability to identify and block illegally imported foreign tobacco products. This measure seeks to protect public health by preventing unauthorized tobacco from entering the U.S. market.

07/21/2026 · Virginia

Health

FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease

The U.S. Food and Drug Administration has granted supplemental approval for Casgevy, a gene therapy. This approval targets children aged two years and older with sickle cell disease or transfusion-dependent beta thalassemia.

07/21/2026 · Virginia

Health

CDC Issues Warning on Frozen Blueberries Amid E. coli Outbreak

The Centers for Disease Control and Prevention announced an E. coli outbreak linked to frozen blueberries. Officials issued a recall for the affected product. Consumers should avoid eating any recalled frozen blueberries.

07/20/2026 · Virginia

Health

New Research Examines AI Speech Analysis for Early Alzheimer's Detection

A new paper in Alzheimer's & Dementia examines how artificial intelligence can analyze speech patterns to detect early signs of cognitive decline. Researchers say the approach could enable earlier treatment and more targeted care strategies.

07/18/2026 · Virginia